Results 31 to 40 of about 4,559,446 (271)

Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis. [PDF]

open access: yesPLoS ONE, 2014
Photo-activation of psoralen with UVA irradiation, referred to as PUVA, is used in the treatment of proliferative skin disorders. The anti-proliferative effects of PUVA have been largely attributed to psoralen intercalation of DNA, which upon UV ...
Wenle Xia   +8 more
doaj   +1 more source

Cutaneous sarcoidosis successfully treated with PUVA therapy [PDF]

open access: diamondPrzegląd Dermatologiczny
Agata Szczecina   +5 more
doaj   +2 more sources

Chronic eczema. The search for treatment of severe forms

open access: yesМедицинский вестник Юга России, 2019
Objective: to study the clinical efficacy of re-PUVA therapy in patients with torpid forms of chronic true hand eczema. Materials and methods: the study involved 78 patients (47 women, 31 men) with severe and moderate forms of chronic true hand eczema ...
Vyacheslav V. Starostenko   +3 more
doaj   +1 more source

Oral PUVA Versus Bath PUVA in Chronic Plaque Psoriasis: A Comparative Study of Efficacy

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2018
Introduction: Phototherapy has long been recognized as beneficial for psoriasis treatment, with a favorable risk- -benefit relation. Photochemotherapy comprises the use of psoralen, either orally (oral PUVA) or topically (bath PUVA), prior to UVA ...
Katarina Kieselova   +2 more
doaj   +1 more source

Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials

open access: yesAnnals of Medicine, 2022
Background Previous studies have proven that ultraviolet (UV)-based phototherapy, including UVB or psoralen UVA (PUVA), and their combination therapies, is effective for psoriasis treatment.
Yajia Li   +6 more
doaj   +1 more source

Comparative Effectiveness and Safety of Methotrexate Versus PUVA in Severe Chronic Stable Plaque Psoriasis

open access: yesIndian Journal of Dermatology, 2021
Background: Psoriasis is a chronic, inflammatory, immune-mediated, debilitating skin disease affecting approximately 2%–3% of the global population.
Saikat Banerjee   +3 more
doaj   +1 more source

PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides

open access: yesCase Reports in Dermatological Medicine, 2017
Background. Bullous pemphigoid is an autoimmune subepidermal blistering skin disease in which autoantibodies are directed against components of the basement membrane.
Birgül Özkesici   +5 more
doaj   +1 more source

Narrow-band mid-wave uгltraviolet therapy in patients with mycosis fungoides [PDF]

open access: yesVestnik Dermatologii i Venerologii
Background. Standardization of the approach to the prescription of UVB-311 in mycosis fungoides is an urgent problem that requires prospective studies aimed at finding the most effective and safe treatment regimens. Aim.
Anastasiia A. Vorontsova   +2 more
doaj   +1 more source

Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it

open access: yesFrontiers in Medicine, 2020
Background: Little is known about psychological discomfort and quality of life (QoL) in early stage mycosis fungoides (MF) and the effect of psoralen plus UV-A (PUVA) on it.Objective: To evaluate QoL, anxiety, and depression with validated instruments in
Thomas Graier   +14 more
doaj   +1 more source

Combination therapies in psoriasis

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Topical corticosteroids and vitamin D analogs can be combined with other topical, systemic, and biological agents. The effect of methotrexate can be enhanced with ultraviolet B (UVB) or psoralen ultraviolet A (PUVA).
Erol Koç, Emel Bülbül Başkan
doaj   +1 more source

Home - About - Disclaimer - Privacy